LAURA MCCLOSKEY: Open Payments
NPI 1891159364 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 26 payments from 5 companies in 2025. Trend: 2023 $267 · 2024 $563 · 2025 $277
Food & beverage: $243Education: $34
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 21 | $145 |
| GENZYME CORPORATION | 1 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Amgen Inc. | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: TRELEGY ELLIPTA, NUCALA, DUPIXENT, TEZSPIRE, Rhapsido.
Industry payments across TN — which companies pay providers there.
